| Issue |
Title |
| Vol 92, No 3 (2020) |
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world |
|
|
Zakiev V.D., Gvozdeva A.D., Martynyuk T.V. |
| Vol 92, No 3 (2020) |
Exacerbation of idiopathic pulmonary fibrosis |
|
|
Avdeev S.N., Gaynitdinova V.V., Merzhoeva Z.M., Neklyudova G.V., Tsareva N.A., Nuralieva G.S. |
| Vol 91, No 1 (2019) |
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry |
|
|
Chazova I.E., Arkhipova O.A., Martynyuk T.V. |
| Vol 91, No 9 (2019) |
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry |
|
|
Chazova I.E., Valieva Z.S., Nakonechnikov S.N., Taran I.N., Martynyuk T.V. |
| Vol 90, No 4 (2018) |
New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension |
|
|
Martynyuk T.V., Nakonechnikov S.N., Chazova I.Y. |
| Vol 86, No 9 (2014) |
Pulmonary hypertension in Russia: The first results of the national register |
|
|
Chazova I.E., Arkhipova O.A., Valieva Z.S., Nakonechnikov S.N., Martyniuk T.V. |
| Vol 85, No 1 (2013) |
Results of implementation of a hypertension control program in Russia in 2002-2012 |
|
|
Chazova I.E., Oshchepkova E.V. |
| Vol 91, No 1 (2019) |
Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension) |
|
|
Chazova I.E., Aksenova A.V., Oschepkova E.V. |
| Vol 90, No 9 (2018) |
Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension) |
|
|
Oshchepkova E.V., Lazareva N.V., Chazova I.E. |
| Vol 85, No 12 (2013) |
Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension |
|
|
Tsareva N.A. |
| Vol 91, No 9 (2019) |
Antihypertensive therapy in men and women in real clinical practice according to the National register |
|
|
Oshhepkova E.V., Aksenova A.V., Orlovskij A.A., Chazova I.E. |
| Vol 78, No 2 (2003) |
Albarel (rilmenidin) - a selective agonist of imidazol receptors. II. Pharmacological properties and experience of clinical use |
|
|
Khirmanov V.N. |
| Vol 91, No 12 (2019) |
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults |
|
|
Shmalts A.A., Gorbachevsky S.V. |
| Vol 90, No 3 (2018) |
Combination therapy is a new standard for treatment of pulmonary arterial hypertension |
|
|
Avdeev S.N., Tsareva N.A., Gaisin I.R. |
| Vol 87, No 1 (2015) |
Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis |
|
|
Volkov A.V., Kurmukov I.A., Iudkina N.N., Glukhova S.I., Nikolaeva E.V. |
| Vol 91, No 3 (2019) |
Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension |
|
|
Sakhnova T.A., Blinova E.V., Belevskaya A.A., Saidova M.A., Arkhipova O.A., Yurasova E.S., Alokova F.H., Martynyuk T.V., Chazova I.Y. |
| Vol 91, No 3 (2019) |
Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension) |
|
|
Chazova I.E., Lazareva N.V., Oshchepkova E.V. |
| Vol 90, No 1 (2018) |
Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension |
|
|
Simakova M.A., Ryzhkov A.V., Kazymly A.V., Naimushin A.V., Lukinov V.L., Moiseeva O.M. |
| Vol 84, No 4 (2012) |
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
|
|
Avdeev S.N. |
| Vol 91, No 9 (2019) |
Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension |
|
|
Podzolkov V.I., Safronova T.A., Natkina D.U. |
| Vol 90, No 9 (2018) |
Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up |
|
|
Glybochko P.V., Svetankova A.A., Rodionov A.V., Maltseva A.S., Sulimov V.A., Fomin V.V. |
| Vol 79, No 9 (2004) |
Arterial hypertension in chronic glomerulonephritis:detectability and treatment efficacy |
|
|
Kutyrina I.M., Martynov S.A., Shvetsov M.Y., Livshits N.L., Miroshnichenko N.G., Golitsina E.P., Varshavsky V.A. |
| No 8 (2003) |
Co-renitek treatment of patients withmoderate and severe forms of hypertensive disease |
|
|
Chazova I.E., Rat ova L.G., Dmhriev V.V., Khanbalaeva M.N., Kolkina T.I. |
| Vol 88, No 9 (2016) |
Analysis of the management of hypertension complications in patients during emergency care |
|
|
Alpysova A.R., Subbota Y.V., Adambekova A.K., Telembetov N.T., Maratkyzy M. |
| Vol 83, No 4 (2011) |
Outpatient prophylaxis and treatment of arterial hypertension with application of mobile telephone systems and internet techniques |
|
|
Kiselev A.R., Shvarts V.A., Posnenkova O.M., Gridnev V.I., Dovgalevskiy P.Y., Oshchepkova E.V., Evstifeeva S.E., Kiselev A.R., Shvarts V.A., Posnenkova O.M., Gridnev V.I., Dovgalevsky P.Y., Oschepkova E.V., Evstifeeva S.E. |
| Vol 81, No 5 (2009) |
Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD) |
|
|
Chazova I.E., Ratova L.G., Chazova I.E., Ratova L.G. |
| Vol 79, No 5 (2004) |
Pulmonary hypertension in patients with systemic sclerosis with CREST-syndrome and without it |
|
|
Karoli N.A., Rebrov A.P., Orlova E.E. |
| Vol 90, No 9 (2018) |
Features of the clinical picture in patients of middle age with essential hypertension |
|
|
Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Pavleyva E.E. |
| Vol 89, No 8 (2017) |
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience |
|
|
Valieva Z.S., Martynyuk T.V., Chazova I.E. |
| Vol 87, No 11 (2015) |
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study |
|
|
Volkov A.V., Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Nasonov E.L. |
| Vol 86, No 1 (2014) |
Association of leptin with obesity and hypertension in an ethnic Kyrgyz group |
|
|
Kerimkulova A.S., Lunegova O.S., Mirrakhimov A.É., Alibaeva N.T., Neronova K.V., Baĭramukova A.A., Mirrakhimov É.M. |
| Vol 84, No 4 (2012) |
CHOICE OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION: SYMPTOMATIC AND BASIC, STANDARD AND SITUATIONAL |
|
|
Gogin E.E. |
| Vol 82, No 6 (2010) |
Calcium antagonists: on the way to expanding the indications |
|
|
Fomin V.V. |
| Vol 79, No 12 (2004) |
Vasoregulating activity of the endothelium and pulmonary hypertension |
|
|
Karoli N.A., Rebrov A.P. |
| Vol 78, No 10 (2003) |
Gestational arterial hypertension.Mechanisms of formation.Treatment with normodipin |
|
|
Davidovich I.M., Bloschinskaya I.A., Petrichko T.A. |
| Vol 91, No 9 (2019) |
Autoantibodies to M2-cholinoreceptors as a potential development factor of arrhythmia in patients with paroxysmal atrial fibrillation |
|
|
Mironova E.S., Mironova N.A., Sharf T.V., Efremov E.E., Azmuko A.A., Molokoedov A.S., Zykov K.A., Golitsyn S.P. |
| Vol 89, No 4 (2017) |
Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study |
|
|
Veselova T.N., Demchenkova A.Y., Martynyuk T.V., Danilov N.M., Ternovoy S.K., Chazova I.E. |
| Vol 87, No 1 (2015) |
Arterial hypertension: An expanding pathogenic continuum and therapeutic limitations |
|
|
Kharchenko E.P. |
| Vol 85, No 9 (2013) |
On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure) |
|
|
Chazova I.E., Martyniuk T.V. |
| Vol 83, No 12 (2011) |
Efficacy of hypobaric hypoxia in the treatment of arterial hypertension in postmenopausal women |
|
|
Tin'kov A.N., Konstantinova O.D., Kshnyaseva S.K., Tinkov A.N., Konstantinova O.D., Kshnyaseva S.K. |
| Vol 81, No 8 (2009) |
Hyperfiltration in hypertensive patients: results of epidemiological studies |
|
|
Arutyunov G.P., Oganezova L.G., Arutyunov G.P., Oganezova L.G. |
| Vol 79, No 6 (2004) |
Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension |
|
|
Butorov I.V., Verbitsky О.N., Butorov S.I. |
| Vol 78, No 4 (2003) |
Leading trends in perfection of diagnosis and growing importance of invasive investigation methods |
|
|
Gogin E.E. |
| No 1 (2009) |
Basic principles of medical aid for patients with a hypertensive crisis |
|
|
Galkin V.A., Tereshchenko S.N., Galkin V.A., Tereschenko S.N. |
| Vol 90, No 4 (2018) |
Modern view on the place of riociguat in the treatment of pulmonary hypertension |
|
|
Valieva Z.S., Taran I.N., Martynyuk T.V., Chazova I.Y. |
| Vol 88, No 9 (2016) |
Association of the -844G>A polymorphism in the catalase gene with the increased risk of essential hypertension in smokers |
|
|
Bushueva O.Y., Ivanov V.P., Ryzhaeva V.N., Ponomarenko I.V., Churnosov M.I., Polonikov A.V. |
| Vol 86, No 9 (2014) |
Hemodynamic effects of the synthetic analogue of endogenous nitric oxide (II) donors a dinitrosyl iron complex in hypertensive patients with uncomplicated hypertensive crisis |
|
|
Gosteev A.I., Zorin A.V., Rodnenkov O.V., Dragnev A.G., Chazov E.I. |
| Vol 84, No 10 (2012) |
Blood pressure variability and risk for complications in arterial hypertension |
|
|
Ostroumova O.D. |
| Vol 83, No 4 (2011) |
Changes in orthogonal ECG in hypertensive patients taking different antihypertensive therapy |
|
|
Sakhnova T.A., Blinova E.V., Ryabykina G.V., Shutova L.I., Chikhladze N.M., Martynyuk T.V., Chazova I.E., Sakhnova T.A., Blinova E.V., Ryabykina G.V., Shutova L.I., Chikhladze N.M., Martynyuk T.V., Chazova I.E. |
| Vol 81, No 4 (2009) |
Heart rate variability in migrants to the North with hypertension comorbid with biliary diseases |
|
|
Daryanina S.A., Pal'tsev A.I., Nikolaev Y.A., Daryanina S.A., Paltsev A.I., Nikolaev Y.A. |
| Vol 79, No 3 (2004) |
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension |
|
|
Arkhipova D.V., Privalova E.V., Kozlovskaya L.V., Kornev B.M., Popova E.N., Kraeva V.V., Osipenko V.I., Bitsadze V.O. |
| Vol 89, No 9 (2017) |
Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome |
|
|
Movsisyan G.A., Martynyuk T.V., Mershin K.V., Danilov N.M., Satybaldyeva M.A., Reshetnyak T.M., Akchurin R.S., Nasonov E.L., Chazova I.Y. |
| Vol 87, No 9 (2015) |
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan |
|
|
Avdeev S.N. |
| Vol 84, No 5 (2012) |
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS |
|
|
Volkov A.V., Martynyuk T.V., Yudkina N.N., Danilov N.M., Glukhova S.I., Guseva N.G., Chazova I.E., Nasonova V.A. |
| Vol 82, No 9 (2010) |
Influence of genetic factors on the development of target organ lesions in relation to age at diagnosis of arterial hypertension |
|
|
Kuznetsova T.Y., Gavrilov D.V., Samokhodskaya L.M., Postnov A.Y., Boytsov S.A., Kuznetsova T.Y., Gavrilov D.V., Samokhodskaya L.M., Postnov A.Y., Boitsov S.A. |
| Vol 79, No 12 (2004) |
The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy |
|
|
Ametov A.S., Demidova T.Y., Smagina L.V. |
| Vol 78, No 9 (2003) |
Cardiology: today and tomorrow trends |
|
|
Chazov E.I. |
| Vol 90, No 2 (2018) |
Comorbid for gastroduodenal ulcers in the aspect of calcium imbalance and blockers of slow calcium channels in their treatment |
|
|
Fomina L.A. |
| Vol 89, No 2 (2017) |
Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension |
|
|
Fomina L.A., Chernin V.V. |
| Vol 87, No 1 (2015) |
Clinicoeconomic effectiveness of using psychotherapy to treat patients with essential hypertension |
|
|
Kalmataeva Z.A., Zholamanova A.A. |
| Vol 85, No 5 (2013) |
Problem of a comorbidity of arterial hypertension and acid-dependent diseases |
|
|
Khlynova O.V., Tuev A.V., Beresneva L.N., Agafonov A.V. |
| Vol 83, No 10 (2011) |
Clinical implication of endothelial dysfunction in patients with essential arterial hypertension and urate dysbolism with renal damage |
|
|
Stakhova T.Y., Pulin A.A., Severova M.M., Shovskaya T.N., Minakova E.G., Oleynikova E.B., Lebedeva M.V., Stakhova T.Y., Pulin A.A., Severova M.M., Shovskaya T.N., Minakova E.G., Oleinikova E.B., Lebedeva M.V. |
| Vol 81, No 9 (2009) |
Blood lipid spectrum in hypertensive patients and normotensive subjects living in the Khanty-Mansiysk region |
|
|
Mikhaylova I.M., Gapon L.I., Belousov V.V., Startseva O.N., Alekseeva S.V., Mikhailova I.M., Gapon L.I., Belousov V.V., Startseva O.N., Alexeeva S.V. |
| Vol 79, No 6 (2004) |
Peculiarity of hypotensive efficacy in hypertensive patients with desaturation signs of obstructive sleep apnea syndrome |
|
|
Zelveian I.A., Oschepkova E.V., Buniatian M.S., Rogoza A.N. |
| No 8 (2003) |
How we treat patients withcardiovascular diseases in real clinical practice |
|
|
Belenkov Y.N., Mareev V.Y. |
| Vol 90, No 4 (2018) |
Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension |
|
|
Mironchuk N.N., Amineva L.K., Mirsaeva G.K., Yunusova A.S. |
| Vol 88, No 8 (2016) |
Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension |
|
|
Sevostyanova E.V., Nikolaev Y.A., Bogdankevich N.V., Lusheva V.G., Markova E.N., Dolgova N.A. |
| Vol 86, No 9 (2014) |
Molecular genetic markers of predisposition to thrombosis in adolescents with essential hypertension |
|
|
Dolgikh V.V., Bol'shakova S.E., Kolesnikova L.I., Mikhalevich I.M. |
| Vol 84, No 12 (2012) |
Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study |
|
|
Martyniuk T.V., Konosova I.D., Chazova I.E. |
| Vol 83, No 5 (2011) |
Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis |
|
|
Novikova D.S., Popkova T.V., Nasonov E.L., Novikova D.S., Popkova T.V., Nasonov E.L. |
| Vol 81, No 4 (2009) |
Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity |
|
|
Kazymov M.S., Fishman B.B., Veber V.R., Fishman M.B., Kopina M.N., Kuprin P.E., Kazymov M.S., Fishman B.B., Veber V.R., Fishman M.B., Kopina M.N., Kuprin P.E. |
| Vol 79, No 1 (2004) |
Diagnosis of disturbed lipid and carbohydrate metabolism in hypertensive women in outpatient setting |
|
|
Polyatykina T.S., Al-sveirki A.D., Poltyrev V.S., Romanenko I.A., Budnikova N.V., Mishina I.E., Ivanova G.V. |
| Vol 90, No 9 (2018) |
Arterial hypertension in the light of current recommendations |
|
|
Chazova I.E. |
| Vol 89, No 12 (2017) |
A retrospective historical study evaluating the safe use of current antidepressants in cardiology practice |
|
|
Ivanov S.V., Volel B.A., Syrkina E.A., Ternovaya E.S., Troshina D.V., Grubova M.V., Tolkacheva I.A., Rozhkov A.N., Simonov A.N. |
| Vol 87, No 8 (2015) |
Chronic obstructive pulmonary disease concurrent with hypertension: Evaluation of the therapeutic effect of prolonged-release indapamide |
|
|
Ovcharenko S.I., Morozova T.E., Nersesyan Z.N. |
| Vol 85, No 9 (2013) |
Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches |
|
|
Rasin M.S. |
| Vol 84, No 4 (2012) |
LEFT ATRIAL DEFORMATION IN HYPERTENSIVE PATIENTS WITH AORTIC STENOSIS AND LEFT VENTRICULAR HYPERTROPHY OF DIFFERENT SEVERITY |
|
|
Kalinin A., Alekhin M.N., Bachs G., Leinieks A., Kalninsh S., Schipachov P. |
| Vol 82, No 9 (2010) |
Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between the blood pressure achieved with antihypertensive therapy and the body weight |
|
|
Karpov O.A., Koshel'skaya R.S., Khoroshilova I.V., Karpov R.S., Koshelskaya O.A., Khoroshilova I.V. |
| Vol 79, No 10 (2004) |
Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension |
|
|
Mazo E.В., Shashin M.N. |
| Vol 78, No 6 (2003) |
Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater? |
|
|
Chazora I.E. |
| Vol 89, No 1 (2017) |
Association of the polymorphic marker Glu23Lys in the KCNJ11 gene with hypertension in Kyrgyz patients |
|
|
Isakova Z.T., Talaibekova E.T., Asambaeva D.A., Kerimkulova A.S., Lunegova O.S., Aldashev A.A. |
| Vol 85, No 10 (2013) |
Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial |
|
|
Chazova I.E., Martyniuk T.V. |
| Vol 83, No 12 (2011) |
Structural and functional parameters of the vascular bed in premenopausal hypertensive women |
|
|
Khabibulina M.M., Khabibulina M.M. |
| Vol 81, No 9 (2009) |
Structural-functional properties of the vascular wall in hypertensive patients with coronary heart disease: effects of felodipin and perindopril |
|
|
Musikhina N.A., Yuferova O.V., Gapon L.I., Makhneva E.A., Belikova E.A., Petelina T.I., Todosiychuk V.V., Musikhina N.A., Yuferova O.V., Gapon L.I., Makhneva E.A., Belikova E.A., Petelina T.I., Todosiychuk V.V. |
| Vol 79, No 4 (2004) |
Self-control of arterial pressure at home as a method of improving compliance in hypertensive patients |
|
|
Oschepkova E.V., Tsagareishvili E.V., Zelveyan P.A., Rogoza A.N. |
| Vol 78, No 2 (2003) |
Function of circulation system in the course of arterial hypertension treatment in patients with vibration disease |
|
|
Shpagina L.A., Tretyakov S.V., Voitovich T.V. |
| Vol 90, No 4 (2018) |
Differences between passport and biological (actual) age in the population of Russian patients suffering from arterial hypertension (analysis of the «Hyperion» register) |
|
|
Arutyunov A.G., Nozdrin A.V., Shavgulidze K.B., Tokmin D.S., Osadchiy I.V. |
| Vol 88, No 8 (2016) |
Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation |
|
|
Ripp T.M., Rebrova T.Y., Mordovin V.F., Afanasiev S.A., Pekarsky S.E., Semke G.V., Falkovskaya A.Y., Lichikaki V.A., Tsymbalyuk E.V. |
| Vol 86, No 9 (2014) |
24-hour systolic wave increment index monitoring in patients with low-renin arterial hypertension |
|
|
Valieva Z.S., Chikhladze N.M., Rogoza A.N., Iarovaia E.B., Bosykh E.G., Chazova I.E. |
| Vol 84, No 9 (2012) |
Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy |
|
|
Shostak N.A., Klimenko A.A., Novikov I.V., Demidova N.A., Aksenova A.V. |
| Vol 83, No 4 (2011) |
Microcirculatory disorders in hypertension, atherosclerosis, diabetes mellitus |
|
|
Gogin E.E., Gogin E.E. |
| Vol 81, No 2 (2009) |
Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus |
|
|
Nestepov Y.I., Bondapeva I.N., Teplyakov A.T., Poltavtseva O.V., Nesterov Y.I., Bondareva I.N., Teplyakov A.T., Poltavtseva O.V. |
| Vol 78, No 12 (2003) |
Microalbuminuria: clinical and prognostic value in arterial hypertension |
|
|
Arakelyants A.A., Zhukova N.V., Ryazanov A.S., Yurenev A.P. |
| Vol 92, No 1 (2020) |
Hypertension and insomnia |
|
|
Ostroumova T.M., Parfenov V.A., Ostroumova O.D., Kochetkov A.I. |
| Vol 91, No 2 (2019) |
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy |
|
|
Maevskaya M.V., Ivashkin V.T., Ivashkin K.V., Lunkov V.D., Liusina E.O., Zozula V.N., Leshchenko V.I. |
| Vol 89, No 9 (2017) |
Genetic determinants of hypertension in two national cohorts of Mountain Shoria |
|
|
Barbarash О.L., Voevoda М.I., Artamonova G.V., Mulerova Т.А., Voropaeva Е.N., Maksimov V.N., Ogarkov М.Y. |
| Vol 87, No 6 (2015) |
Hemodynamic effects of succinate-containing dialyzing solution |
|
|
Smirnov A.V., Golubev R.V., Vasiliev A.N., Zemchenkov A.Y., Staroselsky K.G. |
| Vol 85, No 9 (2013) |
What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug? |
|
|
Adasheva T.V., Samorukova E.I., Zadionchenko V.S., Nesterenko O.I. |
| Vol 84, No 4 (2012) |
CURRENT APPROACHES TO ASSESSMENT OF LEFT VENTRICULAR HYPERTROPHY ASPECTS OF DIFFERENTIAL DIAGNOSIS |
|
|
Saidova M.A. |
| Vol 82, No 6 (2010) |
Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate tubulointerstitial nephritis |
|
|
Lebedeva M.V., Stakhova T.Y., Zaitseva L.I., Selivanova O.Y., Severova M.M. |
| Vol 79, No 11 (2004) |
Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients |
|
|
Markova L.I., Kuznetsova I.V., Radzevich A.E. |
| Vol 78, No 3 (2003) |
Pathogenesis of arterial hypertension within the metabolic syndrome |
|
|
Ryazanov A.S., Arakelyants A.A., Yurenev A.P. |
| Vol 91, No 9 (2019) |
Epicardial adipose tissue as a marker of visceral obesity and its association with metabolic parameters and remodeling of the left chambers of the heart in young people with abdominal obesity |
|
|
Blinova N.V., Azimova M.O., Zhernakova Y.V., Zheleznova E.A., Yarovaya E.B., Orlovskiy A.A., Azimova M.R., Dobrovolskaya S.V., Ternovoy S.K., Chazova I.E. |
| Vol 90, No 3 (2018) |
Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease |
|
|
Aksenova T.A., Gorbunov V.V., Tsarenok S.Y. |
| Vol 88, No 12 (2016) |
Adiponectin in health and disease |
|
|
Tereshchenko I.V., Kamenskikh Y.A., Suslina A.A. |
| Vol 86, No 12 (2014) |
Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case |
|
|
Poteshkina N.G., Khashieva F.M. |
| Vol 85, No 8 (2013) |
Chronic obstructive pulmonary disease and comorbidities |
|
|
Chuchalin A.G. |
| Vol 83, No 8 (2011) |
Modern conceptions of an uric acid role in development of essential hypertension |
|
|
Polovitkina O.V., Oshchepkova E.V., Dmitriev V.A., Titov V.N., Polovitkina O.V., Oschepkova E.V., Dmitriev V.A., Titov V.N. |
| Vol 81, No 8 (2009) |
Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys |
|
|
Borovkova N.Y., Borovkov N.N., Sidnev B.N., Obukhova E.O., Borovkova N.Y., Borovkov N.N., Sidnev B.N., Obukhova E.O. |
| Vol 79, No 5 (2004) |
Grounds for development of endothelial dysfunction in rheumatoid arthritis |
|
|
Rebrov A.P., Inamova О.V. |
| Vol 78, No 1 (2003) |
Prognostic significance of nocturnal fall of systolic arterial pressure in patients with mild and moderate essential hypertension (7-9-year prospective trial) |
|
|
Zelveian P.A., Oschepkova E.V., Buniatian M.S., Rogoza A.N., Sergakova L.M., Varakin Y.Y., Gornostaeva G.V. |
| Vol 90, No 4 (2018) |
Pharmacotherapy of resistant arterial hypertension |
|
|
Shepeleva N.E., Rodionov A.V., Fomin V.V. |
| Vol 88, No 7 (2016) |
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension |
|
|
Avdeev S.N. |
| Vol 86, No 9 (2014) |
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension |
|
|
Chazova I.E., Avdeev S.N., Tsareva N.A., Volkov A.V., Martyniuk T.V., Nakonechnikov S.N. |
| Vol 84, No 9 (2012) |
Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension |
|
|
Martyniuk T.V., Arkhipova O.A., Kobal' E.A., Danilov N.M., Chazova I.E. |
| Vol 83, No 1 (2011) |
Some problems of pathogenesis and clinical symptoms of atherosclerosis (coronary heart disease, hypertension) in the Far North |
|
|
Tikhonov D.G., Nikolaev V.P., Sedalishchev V.I., Tikhonov D.G., Nikolaev V.P., Sedalischev V.I. |
| Vol 81, No 3 (2009) |
Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role |
|
|
Mukhin N.A., Fomin V.V., Popova E.N., Kuznetsova A.V., Popova I.A., Churganova L.Y., Osipenko V.I., Mukhin N.A., Fomin V.V., Popova E.N., Kuznetsova A.V., Popova I.A., Churganova L.Y., Osipenko V.I. |
| Vol 78, No 11 (2003) |
Impact of long-term antihypertensive therapy on the vasoregulating function of the brachial artery in patients with arterialhypertension associated with type 2 diabetes mellitus |
|
|
Karpov R.S., Koshelskaya O.A., Falkovskaya A.Y., Ocheredko N.A., Atroshenkov A.V., Makarova Y.V. |
| Vol 92, No 1 (2020) |
Assessment of the clinical efficacy of telemonitoring and distant counseling in patients with uncontrolled hypertension |
|
|
Ionov M.V., Zhukova O.V., Zvartau N.E., Kurapeev D.I., Yudina Y.S., Konradi A.O. |
| Vol 91, No 2 (2019) |
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study |
|
|
Nadinskaia M.Y., Kodzoeva K.B., Ulyanova K.A., Volkova A.S., Rogacheva S.I., Dekhanov A.S., Strelkova D.A., Ivashkin V.T. |
| Vol 89, No 8 (2017) |
Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program |
|
|
Ostroumova O.D. |
| Vol 87, No 6 (2015) |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
|
Milovanova L.Y., Milovanov Y.S., Kudryavtseva D.V., Markina M.M., Milovanova S.Y., Kozlovskaya L.V., Lebedeva M.V., Beketov V.D., Moiseev S.V., Mukhin N.A., Fomin V.V., Svistunov A.A. |
| Vol 85, No 9 (2013) |
The specific features of hypertension and the choice of treatment policy in old women |
|
|
Podzolkov V.I., Bragina A.E., Nikitina T.I. |
| Vol 84, No 3 (2012) |
SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS |
|
|
Neklyudova G.V., Avdeev S.N., Tsareva N.A., Chernyaev A.L., Samsonova M.V., Naumenko Z.K., Mikhale L.M. |
| Vol 82, No 6 (2010) |
Phosphorus and calcium metabolism and the cardiovascular system in patients with early-stage chronic renal disease |
|
|
Smirnov A.V., Volkov M.M., Dobronravov V.A., Rafrafi H. |
| Vol 79, No 11 (2004) |
Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome |
|
|
Rovda Y.I., Kazakova L.M., Rovda T.S., Rovda E.Y. |
| Vol 78, No 6 (2003) |
Arterial hypertension, its metabolic aspects and function of the kidneys inconvalescents after hemorrhagic fever with renal syndrome |
|
|
Pimenov L.Т., Dudarev M.V., Vasilyev M.Y. |
| Vol 91, No 9 (2019) |
Treatment of ARVI and influenza in patients with arterial hypertension |
|
|
Silina E.V., Sitnikov I.G., Fazylov V.C., Yeganyan G.A. |
| Vol 88, No 9 (2016) |
Occupational factors and a risk of cardiovascular diseases |
|
|
Strizhakov L.A., Lebedeva M.V., Fomin V.V., Muhin N.A. |
| Vol 86, No 9 (2014) |
Practical aspects of treatment in patients with chronic cerebral ischemia and hypertension in general somatic practice |
|
|
Lebedeva M.V. |
| Vol 85, No 5 (2013) |
Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension |
|
|
Iskenderov B.G., Budagovskaia Z.M., Sisina O.N. |
| Vol 83, No 9 (2011) |
High arterial rigidity is a significant but not obligatory factor of arterial hypertension in persons over 60 years of age |
|
|
Boytsov S.A., Rogoza A.N., Kanishcheva E.M., Luk'yanov M.M., Boitsov S.A., Rogoza A.N., Kanischeva E.M., Lukianov M.M. |
| Vol 81, No 9 (2009) |
Risk of cardiovascular complications in patients with frequent hypertensive crises |
|
|
Kolos I.P., Chazova I.E., Tereshchenko S.N., Nakonechnikov S.N., Kolos I.P., Chazova I.E., Tereschenko S.N., Nakonechnikov S.N. |
| Vol 79, No 6 (2004) |
Cerebrovascular complications in metabolic syndrome: possible approaches to a lower risk |
|
|
Chazova I.E., Mychka V.В., Mamyrbaeva К.М., Gornostaev V.V., Dvoskina I.M., Sergienko V.B. |
| Vol 78, No 1 (2003) |
Effects of combined treatment ' with enalapril maleate and hypothiazide on structural-functional state of red cell membranes in hypertensive patients |
|
|
Kuryata A.V., Geichenko V.P. |
| Vol 90, No 9 (2018) |
Vitamin D deficiency and cardiovascular pathology |
|
|
Podzolkov V.I., Pokrovskaya A.E., Panasenko O.I. |
| Vol 89, No 12 (2017) |
A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia |
|
|
Podzolkov V.I., Bragina A.E., Osadchiy K.K. |
| Vol 88, No 8 (2016) |
Possibility of evaluating the effectiveness of renal artery sympathetic denervation in resistant hypertension early after radiofrequency ablation |
|
|
Rebrova T.Y., Ripp T.M., Afanasiev S.A., Mordovin V.F., Muslimova E.F. |
| Vol 86, No 6 (2014) |
Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (Β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders |
|
|
Stakhova T.I., Shcherbak A.V., Kozlovskaia L.V., Taranova M.V., Balkarov I.M. |
| Vol 84, No 11 (2012) |
Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes |
|
|
Kovalenko V.N., Talaeva T.V., Shumakov V.A., Bratus' V.V. |
| Vol 83, No 2 (2011) |
Fundoplication as prophylaxis of reflux-esophagitis in patients with varicose esophageal veins |
|
|
Vasnev O.S., Yanova O.B., Kovyazina I.O., Vasnev O.S., Yanova O.B., Kovyazina I.O. |
| Vol 81, No 4 (2009) |
Quantitative repolarization indices in diagnosis of left ventricular hypertrophy in hypertensive patients |
|
|
Sakhnova T.A., Blinova E.V., Sergakova L.M., Ataullakhanova D.M., Chazova I.E., Sakhnova T.A., Blinova E.V., Sergakova L.M., Ataullakhanova D.M., Chazova I.E. |
| Vol 78, No 12 (2003) |
Administration of enalapril for preparation ofpatients with arterial hypertension to surgical interventions |
|
|
Proschaev K.I. |
| Vol 91, No 12 (2019) |
Features of central hemodynamics in patients with community - acquired pneumonia depending on the course of the disease and cardiovascular comorbidity |
|
|
Titova O.N., Kuzubova N.A., Aleksandrov A.L., Perley V.E., Volchkova E.V., Baryshnikova K.A. |
| Vol 91, No 1 (2019) |
Relationships of arterial hypertension and reduced renal function in a population 25-45 years |
|
|
Kovalkova N.A., Ragino Y.I., Scherbakova L.V., Hudyakova A.D., Denisova D.V., Voevoda M.I. |
| Vol 89, No 8 (2017) |
Efficiency of triple antihypertensive therapy in patients with uncontrolled hypertension and depressive disorders |
|
|
Skibitsky V.V., Fendrikova A.V., Skibitsky A.V. |
| Vol 87, No 5 (2015) |
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases |
|
|
Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Novikova D.S., Markelova E.I., Volkov A.V. |
| Vol 85, No 12 (2013) |
Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus |
|
|
Statsenko M.E., Derevianchenko M.V., Titarenko M.N., Mikhaleva A.V. |
| Vol 84, No 1 (2012) |
New guidelines for hypertension in Russia - a priority of combined treatment |
|
|
Karpov Y.A., Karpov Y.A. |
| Vol 82, No 5 (2010) |
Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis |
|
|
Shilkina N.P., Yunonin I.E., Stolyarova S.A., Dryazhenkova I.V., Shilkina N.P., Yunonin I.E., Stolyarova S.A., Dryazhenkova I.V. |
| Vol 79, No 10 (2004) |
Metabolic syndrome of insulin resistance: basic conception and consequences (a review) |
|
|
Starkova N.Т., Dvoryashina I.V. |
| Vol 78, No 3 (2003) |
Use of nebivolol in patients with mild and moderate hypertensive disease |
|
|
Zhigunova L.V., Lakhova Y.L., Yurenev A.P. |
| Vol 91, No 4 (2019) |
Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension |
|
|
Danilov N.M., Matchin Y.G., Chernyavsky A.M., Edemsky A.G., Grankin D.S., Sagaydak O.V., Chazova I.E., Boytsov S.A., Karaskov A.M. |
| Vol 90, No 1 (2018) |
Stress in the family - association with prevalence of cardiovascular diseases in men of the open city population |
|
|
Akimova E.V., Akimov M.J., Gakova E.I., Kayumova M.M., Gafarov V.V., Kuznetsov V.A. |
| Vol 88, No 12 (2016) |
A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension |
|
|
Arkhipova O.A., Martynyuk T.V., Chazova I.E. |
| Vol 86, No 8 (2014) |
Neuroprotection in hypertensive patients: Minimization of poor prognosis |
|
|
Shishkova V.N. |
| Vol 85, No 6 (2013) |
Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region) |
|
|
Nagaĭtseva S.S., Shaliagin I.D., Shvetsov M.I., Piagaĭ N.L., Ivanova E.S., Shilov E.M. |
| Vol 83, No 5 (2011) |
Efficacy of combined treatment of patients with severe obstructive sleep apnea and arterial hypertension of the second and third degree |
|
|
Sukmarova Z.N., Litvin A.Y., Chazova I.E., Rogoza A.N., Sukmarova Z.N., Litvin A.Y., Chazova I.E., Rogoza A.N. |
| Vol 81, No 8 (2009) |
Renin as a target of direct pharmacological block in arterial hypertension |
|
|
Mukhin N.A., Fomin V.V., Mukhin N.A., Fomin V.V. |
| Vol 79, No 4 (2004) |
Methodological approaches to estimation of a morning urge of arterial pressure in essential hypertensives |
|
|
Lazareva N.V., Oschepkova E.V., Zelveyan P.A., Buniatyan M.S., Rogoza A.N. |
| Vol 78, No 1 (2003) |
A 24-h arterial pressure profile in patients with arterial hypertension living in Tyumen North |
|
|
Gapon L.I., Sereda T.V., Shurkevich N.P., Shanaurina N.V. |
| Vol 90, No 9 (2018) |
Arterial hypertension at the workplace: risk factors and the population value |
|
|
Strizhakov L.A., Babanov S.A., Lebedeva M.V., Moiseev S.V., Fomin V.V. |
| Vol 89, No 12 (2017) |
Diagnosis and treatment of pulmonary hypertension: from the point of view of 2017 |
|
|
Sarybaev A.S., Sydykov A.S., Sartmyrzaeva M.A., Mamazhakypov A.T., Maripov A.M., Dzhumagulova A.S. |
| Vol 88, No 6 (2016) |
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease |
|
|
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M. |
| Vol 86, No 5 (2014) |
The specific features of gout in the elderly |
|
|
Tsurko V.V., Eliseeva M.E., Vorob'ev P.A. |
| Vol 84, No 12 (2012) |
Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril |
|
|
Musikhina N.A., Gapon L.I., Utesheva A.B., Petelina T.I., Kolesnikova S.N. |
| Vol 82, No 11 (2010) |
Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension |
|
|
Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoylenko L.E., Chazova I.E., Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoilenko L.E., Chazova I.E. |
| Vol 80, No 12 (2008) |
Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients |
|
|
Petriy V.V., Sergushkina N.G., Brazhnik V.A., Makolkin V.I., Petry V.V., Sergushkina N.G., Brazhnik V.A., Makolkin V.I. |
| Vol 78, No 12 (2003) |
Nifedipine-retard alone and incombination with metoprolol: comparative efficacy andsafety in patients with arterial hypertension |
|
|
Isaikina O.Y., Gorbunov V.M., Andreeva G.F., Dmitrieva N.A., Martsevich S.Y. |
| Vol 92, No 1 (2020) |
The epidemiological situation as a factor determining the strategy for reducing mortality in the Russian Federation |
|
|
Boytsov S.A., Shalnova S.A., Deev A.D. |
| Vol 90, No 12 (2018) |
Interrelation of erectile dysfunction with obesity in patients with arterial hypertension |
|
|
Alekseeva T.A., Shariya M.A., Gamidov S.I., Elfimova E.M., Starostin I.V., Litvin A.Y., Chazova I.E. |
| Vol 89, No 9 (2017) |
Influence of modifiable cardiovascular risk factors on antihypertensive therapy efficiency escape |
|
|
Mikhailova O.O., Litvin A.Y., Rogoza A.N. |
| Vol 87, No 4 (2015) |
HIV/AIDS masks in a therapist’s practice |
|
|
Roshchina A.A., Ponomareva E.Y., Rebrov A.P. |
| Vol 85, No 10 (2013) |
The vascular wall in postmenopausal women with hypothyroidism and hypertension |
|
|
Riabtseva O.I., Orlova I.A., Blankova Z.N., Chazova T.E., Ageev F.T. |
| Vol 84, No 1 (2012) |
Hypertension in pregnant women - a novel cardiorenal continuum |
|
|
Gaysin I.R., Gaisin I.R. |
| Vol 82, No 4 (2010) |
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies |
|
|
Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E., Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E. |
| Vol 79, No 8 (2004) |
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension |
|
|
Popova E.N., Bolevich S.В., Litvitsky P.E., Arkhipova D.V., Osipenko V.I., Kogan E.A., Kornev В.М., Mukhin N.A. |
| Vol 78, No 3 (2003) |
Correlation between left ventricular hypertrophy and diastolic dysfunction in arterial hypertension |
|
|
Trushinsky Z.К., Dovgalyuk Y.V., Skritskaya О.Y. |
| No 1 (2009) |
Genetic determinants of cardiovascular remodeling n Urbek patients with essential hypertension |
|
|
Eliseeva M.R., Srozhidinova N.Z., Khamidullaeva G.A., Abdullaeva G.Z., Eliseeva M.R., Srozhidinova N.Z., Khamidullaeva G.A., Abdullaeva G.Z. |
| Vol 90, No 1 (2018) |
Cardiovascular disease and associated comorbid conditions as determinants of adverse perinatal outcomes in pregnancy - an analysis of the results of the register of pregnant BEREG |
|
|
Stryuk R.I., Burns C.A., Filippov M.P., Brytkova Y.V., Borisov I.V., Barkova E.L., Gomova T.A., Kozina E.A., Nagirnyak O.A. |
| Vol 88, No 9 (2016) |
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1) |
|
|
Chazova I.E., Martynyuk T.V. |
| Vol 86, No 9 (2014) |
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril |
|
|
Morozova T.E., Gontarenko S.V., Kuz'mina E.R. |
| Vol 85, No 6 (2013) |
New markers of cardio-renal links in chronic kidney disease |
|
|
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A. |
| Vol 83, No 4 (2011) |
A protective effect of Gly272Ser polymorphism of GNB3 gene in development of essential hypertension and its relations with environmental hypertension risk factors |
|
|
Polonikov A.V., Solodilova M.A., Ivanov V.P., Shestakov A.M., Ushachev D.V., Vyalykh E.K., Vasil'eva O.V., Polyakova N.V., Antsupov V.V., Kabanina V.A., Kupriyanova Y.S., Bulgakova I.V., Kozhukhov M.A., Tevs D.S., Polonikov A.V., Solodilova M.A., Ivanov V.P., Shestakov A.M., Ushachev D.V., Vyalykh E.K., Vasilyeva O.V., Polyakova N.V., Antsupov V.V., Kabanina V.A., Kupriyanova Y.S., Bulgakova I.V., Kozhukhov M.A., Tevs D.S. |
| Vol 81, No 7 (2009) |
Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in subleukemic myelosis and congenital immunodeficiency |
|
|
Lukina E.A., Sysoeva E.P., Kitsenko E.A., Varlamova E.Y., Inozemtseva M.V., Semenova E.A., Nadinskaya M.Y., Ivashkin V.T., Lukina E.A., Sysoeva E.P., Kitsenko E.A., Varlamova E.Y., Inozemtseva M.V., Semeniova E.A., Nadinskaya M.Y., Ivashkin V.T. |
| Vol 79, No 3 (2004) |
Prostaglandin E1. Mechanisms of action and clinical potentialities |
|
|
Alferov A.V., Aizenberg L.V. |
| Vol 90, No 9 (2018) |
Worksite hypertension as a model of stress-induced arterial hypertension |
|
|
Ostroumova O.D., Kochetkov A.I. |
| Vol 89, No 12 (2017) |
Melatonin and hypertension: a possible role in combination therapy |
|
|
Budnevsky A.V., Ovsyannikov E.S., Rezova N.V., Shkatova Y.S. |
| Vol 88, No 5 (2016) |
Peripheral vessel wall changes in hypertensive patients with gout |
|
|
Shelest B.A. |
| Vol 86, No 3 (2014) |
Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension |
|
|
Avdeev S.N. |
| Vol 84, No 9 (2012) |
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease |
|
|
Musina N.S., Semenova R.I. |
| Vol 82, No 12 (2010) |
Impact of antihypertensive therapy on clinical Status and quality of life in patients with initial manifestations of hypertensive encephalopathy |
|
|
Varakin Y.Y., Oshchepkova Z.A., Gornostaeva G.V., Amintaeva A.G., Kadykov A.V., Kravchenko M.A., Prokopovich M.E., Manvelov L.S., Suslina E.V., Varakin Y.Y., Oshchepkova E.V., Gornostayeva G.V., Amintayeva A.G., Kadykov A.V., Kravchenko M.A., Prokopovich M.E., Manvelov L.S., Suslina Z.A. |
| Vol 80, No 8 (2008) |
Chronic obstructive pulmonary disease and associated illnesses |
|
|
Chuchalin A.G. |
| Vol 78, No 11 (2003) |
Comparative evaluation of cardiac hemodynamics and endothelium-dependent reactive hyperemia in arterial hypertension in those living in high-altitudeand plain areas |
|
|
Doloman L.В., Beslaneev I.A., Batyrbekova L.M., Kurdanov K.A., Sagach V.F. |
| Vol 91, No 12 (2019) |
Evolution of pathogenetic therapy of pulmonary arterial hypertension |
|
|
Chazova I.E., Yarovoy S.Y., Danilov N.M. |
| Vol 91, No 1 (2019) |
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases |
|
|
Grigoryeva N.Y., Maiorova M.V., Korolyova M.E., Samolyuk M.O. |
| Vol 89, No 3 (2017) |
Hypertensive urgency or high blood pressure variability? |
|
|
Rodionov A.V. |
| Vol 87, No 3 (2015) |
Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial) |
|
|
Kobalava Z.D., Kotovskaya Y.V., Khodorovich N.A. |
| Vol 85, No 8 (2013) |
Neyromidin in the treatment of Stage I hypertensive dyscirculatory encephalopathy |
|
|
Maksimova M.I., Okhtova F., Sineva N.A., Vodop'ianov N.P. |
| Vol 83, No 12 (2011) |
Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver |
|
|
Mikheeva O.M., Drozdov V.N., Komisarenko I.A., Mikheeva O.M., Drozdov V.N., Komisarenko I.A. |
| Vol 81, No 10 (2009) |
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients |
|
|
Kobalava Z.D., Kotovskaya Y.V., Tyul'kina E.E., Kobalava Z.D., Kotovskaya Y.V., Tyulkina E.E. |
| Vol 79, No 9 (2004) |
Early diagnosis of renaldamage in hypertensive patients |
|
|
Nanchikeeva M.L., Konechnaya E.Y., Bulanov M.N., Gladkaya A.A., Kozlovskaya L.V. |
| Vol 78, No 3 (2003) |
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases |
|
|
Arkhipova D.V., Kornev B.M., Popova E.N., Kogan E.A., Osipenko V.I., Privalova E.V., Kobylensky A.G., Mescheryakova S.A., Efremov E.E. |
| No 8 (2003) |
Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases |
|
|
Kukes V.G., Ostroumova O.D., Mamaev V.I., Batutina A.M., Abakumov Y.E., Zykova A.A. |
| Vol 90, No 1 (2018) |
Realities and prospects of remote blood pressure monitoring in hypertensive patients |
|
|
Boytsov S.A. |
| Vol 88, No 11 (2016) |
Evaluation of the pharmacoeconomic efficacy of prestance in the treatment of hypertensive patients on the basis of the results of the POTENTIAL program |
|
|
Dyakov I.N., Glezer M.G. |
| Vol 86, No 8 (2014) |
Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy |
|
|
Statsenko M.E., Derevianchenko M.V. |
| Vol 85, No 3 (2013) |
Psychosomatic relationships in postmenopausal women |
|
|
Lareva N.V., Govorin A.V. |
| Vol 83, No 3 (2011) |
The role of free radical oxidation and endothelial dysfunction in the onset and progression of chronic obstructive pulmonary disease |
|
|
Kuznetsov A.N., Grigor'eva N.Y., Sharabrin E.G., Kuznetsov A.N., Grigorieva N.Y., Sharabrin E.G. |
| Vol 81, No 6 (2009) |
Affection of target organs in hypertensive patients with and without metabolic syndrome |
|
|
Sharipova G.K., Saidova M.A., Balakhonova T.V., Mychka V.B., Chazova I.E., Sharipova G.K., Saidova M.A., Balakhonova T.V., Mychka V.B., Chazova I.E. |
| Vol 79, No 6 (2004) |
Polymorphic markers of GNB3 (C825T), AGTR1 (A1166C) and ACE (A2350G and I/D) genes in patients with arterial hypertension combined with diabetes mellitus type 2 |
|
|
Karpov R.S., Puzyrev K.V., Koshelskaya О.A., Makeeva O.A., Suslova T.E., Efimova E.V., Falkovskaya A.Y., Atroshenkov A.V. |
| Vol 90, No 9 (2018) |
Family hyperaldosteronism type I: a clinical case and review of literature |
|
|
Chikladze N.M., Favorova O.O., Chazova I.E. |
| Vol 89, No 12 (2017) |
Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension |
|
|
Khadartsev A.A., Logatkina A.V., Terekhov I.V., Bondar S.S., Bondar N.V. |
| Vol 88, No 2 (2016) |
Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis |
|
|
Garbuzenko D.V. |
| Vol 86, No 5 (2014) |
Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases |
|
|
Volkov A.V., Iudkina N.N., Nikolaeva E.V., Kurmukov I.A., Glukhova S.I., Nasonov E.L. |
| Vol 84, No 8 (2012) |
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease |
|
|
Semenova R.I., Musina N.S. |
| Vol 82, No 9 (2010) |
Renin inhibitors are a new direction in the treatment of arterial hypertension |
|
|
Vasyuk Y.A., Sadulaeva I.A., Yushchuk E.N., Trofimenko O.S., Chirkov M.V., Fedoseeva V.S., Kulikov K.G., Vasyuk Y.A., Sadulayeva I.A., Yushchuk E.N., Trofimenko O.S., Chirkov M.V., Fedoseyeva V.S., Kulikov K.G. |
| Vol 80, No 6 (2008) |
Bilateral stenosis of renal arteries in a patient with primary antiphospholipid syndrome following hemolyticouremic syndrome (a case report and review of literature) |
|
|
Kozlovskaia N.L., Bobrova L.A., Zakharova E.V., Khafizova E.I., Gagarina N.V., Miroshnichenko N.G. |
| Vol 78, No 12 (2003) |
Variants of venousdysfunction in hypertensive patients with different hemodynamic variants of the disease |
|
|
Khlynova O.V., Tuev A.V., Schekotov V.V. |
| Vol 91, No 9 (2019) |
Risk stratification methods and their significance in pulmonary arterial hypertension |
|
|
Avdeev S.N., Tsareva N.A. |
| Vol 89, No 3 (2017) |
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension |
|
|
Moisseeva O.M., Rudakova A.V. |
| Vol 87, No 4 (2015) |
Specific features of hypertension in patients with systemic lupus erythematosus |
|
|
Savina Z.E., Shilkina N.P. |
| Vol 85, No 9 (2013) |
Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus |
|
|
Statsenko M.E., Derevianchenko M.V., Ostrovskiĭ O.V., Titarenko M.N., Shvets M.K., Bondarev A.M. |
| Vol 83, No 12 (2011) |
Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction |
|
|
Drapkina O.M., Ashikhmin Y.I., Drapkina O.M., Ashikhmin Y.I. |
| Vol 81, No 9 (2009) |
Life devoted to cardiology. The 110 anniversary of professor a. l. Myasnikov's birth |
|
|
Knopov M.M., Taranukha V.K., Knopov M.M., Taranukha V.K. |
| Vol 79, No 8 (2004) |
Structure ofthe sinus dysfunction in hypertensive patients |
|
|
Tuev A.V., Poteshkina N.G., Grigoriadi N.E. |
| Vol 78, No 3 (2003) |
Clinical and functional assessment of daily blood pressure variations in patients with pneumonia |
|
|
Geltser B.I., Kolelnikov V.N., Brodskaya T.A. |
| No 8 (2003) |
Clinical efficiency and tolerance of hydrogensulfide balneotherapy in hypertensive patients living in theclimate of arid zone |
|
|
Zunnunov Z.R. |
| Vol 88, No 10 (2016) |
Obesity in metabolic syndrome, as well as kidney dysfunction |
|
|
Sadulaeva I.A., Vasyuk Y.A., Trofimenko O.S., Yushchuk E.N., Ivanova S.V., Shupenina E.Y., Nesterova E.A. |
| Vol 88, No 9 (2016) |
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension |
|
|
Nevzorova V.A., Kochetkova E.A., Ugay L.G., Maistrovskaya Y.V., Khludeeva E.A. |
| Vol 86, No 12 (2014) |
Estimation of central blood pressure and arterial stiffness in pregnant women with different forms of hypertension |
|
|
Chulkov V.S., Vereina N.K., Sinitsyn S.P., Dolgushina V.F. |
| Vol 85, No 3 (2013) |
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study |
|
|
Avdeev S.N., Tsareva N.A., Nekliudova G.V., Chuchalin A.G. |
| Vol 83, No 4 (2011) |
Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree |
|
|
Belyaeva S.A., Belyaeva S.A. |
| Vol 81, No 5 (2009) |
Contribution of neurohumoral dysfunction and overweight to the course of essential hypertension |
|
|
Bunova S.S., Bunova S.S. |
| Vol 79, No 4 (2004) |
Preclinical diagnosis of renal damage in essential hypertension |
|
|
Grinstein Y.I., Shabalin V.V. |
| Vol 90, No 9 (2018) |
The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation |
|
|
Chazova I.E., Martynyuk T.V., Valieva Z.S., Nakonechnikov S.N., Nedogoda S.V., Salasyuk A.S., Taran I.N., Gratsianskaya S.E. |
| Vol 89, No 10 (2017) |
Progressive pulmonary hypertension in a patient with type 1 Gaucher disease |
|
|
Ponomarev R.V., Model S.V., Averbukh O.M., Gavrilov A.M., Galstyan G.M., Lukina E.A. |
| Vol 87, No 12 (2015) |
Metabolic and hemodynamic effects of the growth hormone system — insulin-like growth factor |
|
|
Manhylova T.A., Gafarova N.H. |
| Vol 86, No 4 (2014) |
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease |
|
|
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A. |
| Vol 82, No 9 (2010) |
Determinants of the respiratory system in hypertensive disease |
|
|
Smakotina S.A., Bazdyrev E.D., Rutkovskaya N.V., Barbarash O.L., Smakotina S.A., Bazdyrev E.D., Rutkovskaya N.V., Barbarash O.L. |
| Vol 80, No 5 (2008) |
Changes in st segment on ecg of hypertensive patients |
|
|
Riabykina G.V., Liutikova L.N., Saidova M.A., Botvina I.V., Kozhemiakina E.I., Shchedrina E.V., Sobolev A.V. |
| Vol 78, No 12 (2003) |
Cerebral perfusion in patients with arterial hypertension and chronic vascular pathology of the brain |
|
|
Geraskina L.A., Suslina Z.A., Fonyakin A.V., Sharypova Т.N. |
| Vol 90, No 10 (2018) |
Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region |
|
|
Kovaleva Y.A., Dreval A.V., Kulakov N.V., Fedorova S.I., Ilovayskaya I.A. |
| Vol 89, No 3 (2017) |
Right ventricular diastolic function in patients with lung diseases in the absence or presence of pulmonary hypertension |
|
|
Sumin A.N., Arkhipov O.G. |
| Vol 87, No 4 (2015) |
Cerebrovascular reactivity in patients with rheumatoid arthritis concurrent with and without hypertension |
|
|
Rebrova N.V., Anisimova E.A., Sarkisova O.L., Mordovin V.F., Karpov R.S., Ripp T.M., Trifonova T.G., Bogomolova I.I. |
| Vol 85, No 9 (2013) |
Comparative characteristics of 24-hour blood pressure profile and heart rate variability in indigenous and non-indigenous patients with chronic coronary heart disease and hypertension from the Yamal-Nenets Autonomic District |
|
|
Gapon L.I., Sereda T.V., Leont'eva A.V., Gul'tiaeva E.P. |
| Vol 83, No 10 (2011) |
Lozartan potential in hyperuricemia correction |
|
|
Nedogoda S.V., Nedogoda S.V. |
| Vol 81, No 9 (2009) |
Natriuretic peptides in diagnosis of pulmonary hypertension |
|
|
Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N., Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N. |
| Vol 79, No 8 (2004) |
Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension |
|
|
Chazova I.E., Mychka V.В., Duishvili D.E. |
| Vol 78, No 3 (2003) |
Change in the activity of angiotensin-converting enzyme in pneumonia and chronic obstructive lung diseases |
|
|
Altshuler B.Y., Roitman A.P., Fedorova T.A., Novazhenov V.G., Belkov S.A., Gordeev M.N., Yarovaya G.A., Neshkova Y.A., Ustinov A.A. |
| No 8 (2003) |
Diroton effects on 24-h fluctuations of arterial pressure as shown bymonitoring in hypertensive patients with polycythemia vera |
|
|
Gorokhovskaya G.N., Zavyalova A.I., Martynov A.I. |
| Vol 88, No 10 (2016) |
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2) |
|
|
Chazova I.E., Martynyuk T.V. |
| Vol 88, No 9 (2016) |
Controlled diuretic monotherapy in hypertensive patients: Efficiency and metabolic safety |
|
|
Semenkin A.A., Zhivilova L.A., Nechaeva G.I., Chindareva O.I., Loginova E.N., Pritykina T.V. |
| Vol 86, No 10 (2014) |
Comparative characteristics of carotid atherosclerosis in patients with hypertension concurrent with chronic coronary heart disease among the indigenous and non-indigenous population of the Yamal-Nenets Autonomic District |
|
|
Gapon L.I., Sereda T.V., Leont'eva A.V., Gul'tiaeva E.P. |
| Vol 85, No 1 (2013) |
Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension |
|
|
Martyniuk T.V., Zykov K.A., Antonova O.I., Rvacheva A.V., Arkhipova O.A., Kobal' E.A., Masenko V.P., Chazova I.E. |
| Vol 83, No 6 (2011) |
Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients |
|
|
Nanchikeeva M.L., Kozlovskaya L.V., Rameev V.V., Fomin V.V., Bulanov N.M., Nanchikeeva M.L., Kozlovskaya L.V., Rameev V.V., Fomin V.V., Bulanov N.M. |
| Vol 81, No 6 (2009) |
Neurohumoral regulation of blood pressure in rheumatic patients |
|
|
Shilkina N.P., Stolyarova S.A., Yunonin I.E., Dryazhenkova I.V., Shilkina N.P., Stolyarova S.E., Dryazhenkova I.V. |
| Vol 79, No 6 (2004) |
Outlook from the past to the future |
|
|
Chazov E.I. |
| Vol 89, No 9 (2017) |
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? |
|
|
Tsareva N.A., Avdeev S.N., Neklyudova G.V. |
| Vol 87, No 12 (2015) |
Hypertension and cognitive impairments: Possible mechanisms of development, diagnosis, and approaches to therapy |
|
|
Zueva I.B. |
| Vol 86, No 2 (2014) |
Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis |
|
|
Garbuzenko D.V. |
| Vol 84, No 6 (2012) |
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE |
|
|
Smirnov A.V., Petrischev N.N., Mnuskina M.M., Panina I.Y., Pumyantsev A.S., Vasina E.Y., Achkasova V.V., Menshutina M.A. |
| Vol 82, No 9 (2010) |
Psychological status of hypertensive patients consuming higher amounts of salt |
|
|
Volkov V.S., Poselyugina O.B., Volkov V.S., Poselyugina O.B. |
| Vol 80, No 2 (2008) |
Features of combined (hbv/hcv-infection) viral lesion of the liver |
|
|
Maev I.V., Nikushkina I.N., Samsonov A.A., Aksel'rod A.G. |
| Vol 78, No 12 (2003) |
The state of theleft ventricle of the heart and 24-h profile of arterial pressure in patients with effort angina and episodes of painlessmyocardial ischemia |
|
|
Mazur E.S., Mazur V.V., Tkhind В., Omar I. |
| Vol 91, No 8 (2019) |
Patient's way from acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: diagnostic and treatment options |
|
|
Edemskiy A.G., Ivanov S.N., Kliver E.N., Novikova N.V., Galstyan M.G., Sevastyanov A.V., Cherniavsky A.M. |
| Vol 90, No 12 (2018) |
The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome |
|
|
Elfimova E.M., Litvin A.Y., Chazova I.E. |
| Vol 89, No 2 (2017) |
Elastography in the diagnosis of portal hypertension in patients with liver cirrhosis |
|
|
Liusina E.O., Pavlov C.S., Ivashkin V.T. |
| Vol 87, No 4 (2015) |
Prognostic value of risk factors for cardiovascular diseases and target organ damages for the occurrence of resistant hypertension |
|
|
Lazutkina A.Y., Gorbunov V.V. |
| Vol 85, No 9 (2013) |
The nature of a microcirculatory change in hypertensive patients during increased blood pressure |
|
|
Vasil'ev A.P., Strel'tsova N.N., Sekisova M.A. |
| Vol 83, No 10 (2011) |
Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome |
|
|
Kseneva S.I., Borodulina E.V., Semiglazova T.A., Kulakova N.V., Tarasova I.V., Udut V.V., Kseneva S.I., Borodulina E.V., Semiglazova T.A., Kulakova N.V., Tarasova I.V., Udut V.V. |
| Vol 81, No 9 (2009) |
Treatment of patients with arterial hypertension and other stroke risk factors in clinical practice. The PROGNOS program |
|
|
Bubnova M.G., Oganov R.G., Bubnova M.G., Oganov R.G. |
| Vol 78, No 4 (2003) |
Current diagnostic and therapeutic aspects of symptomatic arterial hypertension of adrenal genesis |
|
|
Shevchenko Y.P., Vetshev P.S., Podzolkov V.I., Ippolitov L.I., Rodionov A.V., Polunin G.V. |
| 1 - 273 of 273 Items |
|
